Catalogue en ligne OFDT Documentation

Isotonitazene. Report on the risk assessment of N,N-diethyl-2- [[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1Hbenzimidazole- 1-ethanamine (isotonitazene) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended)

Titre :	Isotonitazene. Report on the risk assessment of N,N-diethyl-2- [[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1Hbenzimidazole- 1-ethanamine (isotonitazene) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended)
Auteurs :	OEDT = EMCDDA ; M. EVANS-BROWN ; A. GALLEGOS ; R. SEDEFOV ; A. ALMEIDA ; R. CHRISTIE ; P. DUQUE ; A. GALLEGOS ; R. JORGE ; J. DE MORAIS
Type de document :	Rapport
Editeur :	Lisbon : OEDT / EMCDDA, 2020
Collection :	Risk assessments, ISSN 1725-4493
Format :	55 p.
Langues:	Anglais
Discipline :	PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods)
Mots-clés :	Thésaurus TOXIBASE OPIOIDES ; ANALGESIQUES ; PHENOMENE EMERGENT ; FACTEUR DE RISQUE ; SURVEILLANCE EPIDEMIOLOGIQUE ; CHIMIE ; PHARMACOLOGIE ; TOXICOLOGIE Thésaurus Géographique EUROPE Organismes OEDT
Résumé :	This publication presents the data and findings of the risk assessment on N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1H-benzimidazole-1- ethanamine (isotonitazene), carried out by the extended Scientific Committee of the EMCDDA on 26 May 2020. On the basis of the Risk Assessment Report, on 2 September 2020, the Commission decided that isotonitazene should be included in the definition of 'drug', in the Annex to Framework Decision 2004/757/JHA. Member States shall bring into force the laws, regulations and administrative provisions necessary to comply with Commission Delegated Directive (EU) 2020/1687 by 3 June 2021.
Domaine :	Autres substances / Other substances
Affiliation :	EMCDDA, Lisbon, Portugal ; iKem BT, Budapest, Hungary
Lien :	https://www.emcdda.europa.eu/publications/risk-assessments/isotonitazene_en
Titre précédent :	EMCDDA initial report on the new psychoactive substance N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1H-benzimidazole-1-ethanamine (isotonitazene). In accordance with Article 5b of Regulation (EC) No 1920/2006 (as amended) / OEDT = EMCDDA (2020)